Systematic review with meta-analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systematic review with meta-analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitis
Authors
Keywords
-
Journal
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 47, Issue 12, Pages 1578-1596
Publisher
Wiley
Online
2018-04-26
DOI
10.1111/apt.14672
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tripeptide K(D)PT Is Well Tolerated in Mild-to-moderate Ulcerative Colitis
- (2017) Torsten Kucharzik et al. INFLAMMATORY BOWEL DISEASES
- Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitis
- (2016) W. J. Sandborn et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis
- (2016) Franck Carbonnel et al. GASTROENTEROLOGY
- Efficient Early Drug Development for Ulcerative Colitis
- (2016) Reena Khanna et al. GASTROENTEROLOGY
- Discrepancies between patient-reported outcomes, and endoscopic and histological appearance in UC
- (2016) Jean-Frédéric Colombel et al. GUT
- AVX-470, an Orally Delivered Anti-Tumour Necrosis Factor Antibody for Treatment of Active Ulcerative Colitis: Results of a First-in-Human Trial
- (2016) M. Scott Harris et al. Journal of Crohns & Colitis
- Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis
- (2016) Raja Atreya et al. Journal of Crohns & Colitis
- Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis
- (2016) Vipul Jairath et al. Journal of Crohns & Colitis
- Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis
- (2016) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomised clinical study: discrepancies between patient-reported outcomes and endoscopic appearance in moderate to severe ulcerative colitis
- (2015) B. Jharap et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomised clinical trial: a placebo-controlled study of intravenous golimumab induction therapy for ulcerative colitis
- (2015) P. Rutgeerts et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Budesonide Foam Induces Remission in Patients With Mild to Moderate Ulcerative Proctitis and Ulcerative Proctosigmoiditis
- (2015) William J. Sandborn et al. GASTROENTEROLOGY
- Safety and Efficacy of AJM300, an Oral Antagonist of α4 Integrin, in Induction Therapy for Patients With Active Ulcerative Colitis
- (2015) Naoki Yoshimura et al. GASTROENTEROLOGY
- Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: efficacy and safety from a phase IIa randomised multicentre study
- (2015) Walter Reinisch et al. GUT
- Development and validation of a histological index for UC
- (2015) Mahmoud H Mosli et al. GUT
- Development and validation of the Nancy histological index for UC
- (2015) Aude Marchal-Bressenot et al. GUT
- Low-dose Infliximab for Induction and Maintenance Treatment in Chinese Patients With Moderate to Severe Active Ulcerative Colitis
- (2015) Xue-Liang Jiang et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Twice-daily Budesonide 2-mg Foam Induces Complete Mucosal Healing in Patients with Distal Ulcerative Colitis
- (2015) Makoto Naganuma et al. Journal of Crohns & Colitis
- OP011. Budesonide MMX(R) 9 mg for Inducing Remission in Patients with Mild-to-Moderate Ulcerative Colitis Not Adequately Controlled with Oral 5-ASAs
- (2015) Journal of Crohns & Colitis
- P584. Infliximab therapy for Japanese patients with ulcerative colitis: Efficacy, safety, and association between serum infliximab levels and early response in a randomized, double-blind, placebo-controlled study
- (2015) Journal of Crohns & Colitis
- Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study
- (2015) William J. Sandborn et al. Journal of Crohns & Colitis
- Clinical Trials in Ulcerative Colitis: A Historical Perspective
- (2015) Pieter Hindryckx et al. Journal of Crohns & Colitis
- Association Between Placebo-Activated Neural Systems and Antidepressant Responses
- (2015) Marta Peciña et al. JAMA Psychiatry
- Conducting Meta-Analyses inRwith themetaforPackage
- (2015) Wolfgang Viechtbauer Journal of Statistical Software
- Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study
- (2014) Silvio Danese et al. GUT
- Reproducibility of histological assessments of disease activity in UC
- (2014) Mahmoud H Mosli et al. GUT
- Safety and Activity of Dersalazine Sodium in Patients with Mild-to-moderate Active Colitis
- (2014) Caridad Pontes et al. INFLAMMATORY BOWEL DISEASES
- Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial
- (2014) Séverine Vermeire et al. LANCET
- Current, new and future biological agents on the horizon for the treatment of inflammatory bowel diseases
- (2014) Aurelien Amiot et al. Therapeutic Advances in Gastroenterology
- Randomised clinical trial: evaluation of the efficacy of mesalazine (mesalamine) suppositories in patients with ulcerative colitis and active rectal inflammation - a placebo-controlled study
- (2013) M. Watanabe et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Reliability and Initial Validation of the Ulcerative Colitis Endoscopic Index of Severity
- (2013) Simon P.L. Travis et al. GASTROENTEROLOGY
- The Role of Centralized Reading of Endoscopy in a Randomized Controlled Trial of Mesalamine for Ulcerative Colitis
- (2013) Brian G. Feagan et al. GASTROENTEROLOGY
- Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study
- (2013) Simon P L Travis et al. GUT
- Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study
- (2013) Lloyd Mayer et al. GUT
- Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis
- (2013) Yasuo Suzuki et al. JOURNAL OF GASTROENTEROLOGY
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2013) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Validation of the Ulcerative Colitis Colonoscopic Index of Severity and Its Correlation With Disease Activity Measures
- (2012) Sunil Samuel et al. Clinical Gastroenterology and Hepatology
- Basiliximab Does Not Increase Efficacy of Corticosteroids in Patients With Steroid-Refractory Ulcerative Colitis
- (2012) Bruce E. Sands et al. GASTROENTEROLOGY
- Once-Daily Budesonide MMX® Extended-Release Tablets Induce Remission in Patients With Mild to Moderate Ulcerative Colitis: Results From the CORE I Study
- (2012) William J. Sandborn et al. GASTROENTEROLOGY
- Abatacept for Crohn's Disease and Ulcerative Colitis
- (2012) William J. Sandborn et al. GASTROENTEROLOGY
- A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis
- (2012) Paul J Rutgeerts et al. GUT
- Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2011) William J. Sandborn et al. GASTROENTEROLOGY
- Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis
- (2011) K. Leiper et al. GUT
- Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
- (2011) W. Reinisch et al. GUT
- The mucosal addressin cell adhesion molecule antibody PF-00547,659 in ulcerative colitis: a randomised study
- (2011) S. Vermeire et al. GUT
- Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis
- (2011) Haruhiko Ogata et al. INFLAMMATORY BOWEL DISEASES
- Harnessing the placebo effect: the need for translational research
- (2011) L. Colloca et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data
- (2010) Theo Stijnen et al. STATISTICS IN MEDICINE
- Regulation of Peripheral Inflammation by the Central Nervous System
- (2010) Jean-Marc Waldburger et al. Current Rheumatology Reports
- Safety and Efficacy of a New 3.3 g b.i.d. Tablet Formulation in Patients With Mild-to-Moderately-Active Ulcerative Colitis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
- (2009) Ellen J Scherl et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Rosiglitazone for Active Ulcerative Colitis: A Randomized Placebo-Controlled Trial
- (2008) James D. Lewis et al. GASTROENTEROLOGY
- Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
- (2008) Ted J Kaptchuk et al. BMJ-British Medical Journal
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now